Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Improving drug-target affinity prediction by adaptive self-supervised learning. | PeerJ Comput Sci | 2025 | 39896027 | PubTator, text mining | PubMed |
| Exploiting synthetic lethality in PDAC with antibody drug conjugates and ATR inhibition. | Eur J Med Chem | 2025 | 39874630 | PubTator, text mining | PubMed |
| The use of a ChatGPT-4-based chatbot in teledermatology: A retrospective exploratory study. | J Dtsch Dermatol Ges | 2025 | 39801186 | PubTator, text mining | PubMed |
| OBI-992, a Novel TROP2-Targeted Antibody-Drug Conjugate, Demonstrates Antitumor Activity in Multiple Cancer Models. | Mol Cancer Ther | 2025 | 39786401 | PubTator, text mining | PubMed |
| Dual-Enzyme-Instructed Peptide Self-Assembly to Boost Immunogenic Cell Death by Coordinating Intracellular Calcium Overload and Chemotherapy. | ACS Nano | 2025 | 39754594 | PubTator, text mining | PubMed |
| TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer. | Clin Cancer Res | 2025 | 39745368 | PubTator, text mining | PubMed |
| TDP1 represents a promising therapeutic target for overcoming tumor resistance to chemotherapeutic agents: progress and potential. | Bioorg Chem | 2025 | 39705934 | PubTator, text mining | PubMed |
| Design, synthesis and investigation of biological activity and mechanism of fluoroaryl-substituted derivatives at the FL118 position 7. | Eur J Med Chem | 2025 | 39647420 | PubTator, text mining | PubMed |
| Advancements and challenges of R-loops in cancers: Biological insights and future directions. | Cancer Lett | 2025 | 39613219 | PubTator, text mining | PubMed |
| TEX264-mediated selective autophagy directs DNA damage repair. | Trends Biochem Sci | 2025 | 39550277 | PubTator, text mining | PubMed |
| Presence of RB1 or Absence of LRP1B Mutation Predicts Poor Overall Survival in Patients with Gastric Neuroendocrine Carcinoma and Mixed Adenoneuroendocrine Carcinoma. | Cancer Res Treat | 2025 | 39327909 | PubTator, text mining | PubMed |
| Neopterin mediates sleep deprivation-induced microglial activation resulting in neuronal damage by affecting YY1/HDAC1/TOP1/IL-6 signaling. | J Adv Res | 2025 | 39029901 | PubTator, text mining | PubMed |
| Fluorescence-activated nuclear sorting (FANS) of nuclei from in vitro-generated syncytiotrophoblast. | Placenta | 2025 | 38944560 | PubTator, text mining | PubMed |
| Looping forward: exploring R-loop processing and therapeutic potential. | FEBS Lett | 2025 | 38844597 | PubTator, text mining | PubMed |
| drGT: Attention-Guided Gene Assessment of Drug Response Utilizing a Drug-Cell-Gene Heterogeneous Network. | ArXiv | 2025 | 38800657 | PubTator, text mining | PubMed |
| Synergy between human DNA ligase I and topoisomerase 1 unveils new therapeutic strategy for the management of colorectal cancer. | J Biomol Struct Dyn | 2025 | 38179981 | PubTator, text mining | PubMed |
| Fourier or Wavelet bases as counterpart self-attention in spikformer for efficient visual classification. | Front Neurosci | 2024 | 39944522 | PubTator, text mining | PubMed |
| Assessing diagnostic performance for common skin diseases using an AI-assisted tele-expertise platform: a proof of concept. | Eur J Dermatol | 2024 | 39912464 | PubTator, text mining | PubMed |
| Phosphine Oxide Indenoquinoline Derivatives: Synthesis and Biological Evaluation as Topoisomerase I Inhibitors and Antiproliferative Agents. | Molecules | 2024 | 39770084 | PubTator, text mining | PubMed |
| PNKP safeguards stalled replication forks from nuclease-dependent degradation during replication stress. | Cell Rep | 2024 | 39671289 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=14